Overview

This webinar series will be held monthly and moderated by members of the SCAI Bifurcation Club and Drs. Tanveer Rab, Yiannis Chatzizisis, and J. Dawn Abbott. In each session, three 20-minute cases will be presented with an emphasis on imaging. The discussions will be case-based and will focus predominantly on procedural approaches and techniques. There are no didactic lectures except for guidelines or technical updates. Register now for the entire series.

Learning Objectives

Upon completion of these activities, participants will be able to:

• Assess and apply procedural techniques to treat bifurcation lesions
• Examine imaging modalities and their best applications
• Discuss challenging bifurcation cases
• Explain treatment of bifurcation lesions in the presence of cardiogenic shock and STEMI

Agenda 

• Introduction to Webinar Series—Moderator
• LM Bifurcation CTO—TBD (JBC)
• Retrograde Bifurcation PCI Through SVG—TBD (JBC)
• Wire preferences—TBD (JBC)

Accreditation Statement 

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation 

SCAI designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion

Watch the content and complete the evaluation to obtain credit.

Registration

Cost: Free

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Medtronic.

Disclosures

TBD.

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process 

SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer-reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships

All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins. 

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.

All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection, and analysis. 

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.

Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration (FDA), at first mention and where appropriate in the content.